Avalon Ventures

Enlaza Therapeutics is a biotechnology research company founded in 2020 and based in La Jolla, California. The company focuses on developing novel protein therapeutics aimed at providing more effective and safer treatment options for patients. Utilizing advanced synthetic biology technology, Enlaza's platform enables site-specific covalent coupling driven by drug binding. This innovative approach allows for the creation of first-in-class covalent biologics, which are designed to offer enhanced efficacy and improved safety profiles compared to existing treatments.

Vocera Communications, Inc. specializes in providing secure and integrated communication and workflow solutions tailored for mobile workers across various sectors, including healthcare, hospitality, retail, energy, and education. The company’s offerings enhance communication and operational efficiency by integrating with existing clinical systems, such as electronic health records and nurse call systems. Vocera's product suite includes the Vocera Communication and Workflow System, which connects various communication devices, including hands-free and voice-controlled options, and the Vocera Care Experience software, designed to improve patient care quality and streamline manual tasks. Additionally, Vocera operates the Experience Innovation Network, collaborating with healthcare organizations to develop innovative solutions that improve patient and care team experiences. The company, founded in 2000 and headquartered in San Jose, California, serves approximately 1,700 healthcare facilities globally, including hospitals and clinics, and distributes its products through direct sales, resellers, and distributors.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, that focuses on drug discovery through its innovative platform targeting solute carrier (SLC) transporters. Established in 2016, the company aims to improve patient outcomes by developing small molecule therapies for various diseases, including those related to immunometabolism, lysosomal function, and mucosal defense. By utilizing advanced chemoproteomics techniques, Jnana accelerates the identification of therapeutic targets, addressing significant unmet medical needs in areas such as immuno-oncology, inflammatory disorders, and neurological diseases. The company's approach seeks to enhance drug discovery efficiency by comprehensively targeting the vast family of membrane proteins associated with SLC transporters.

Enlaza Therapeutics is a biotechnology research company founded in 2020 and based in La Jolla, California. The company focuses on developing novel protein therapeutics aimed at providing more effective and safer treatment options for patients. Utilizing advanced synthetic biology technology, Enlaza's platform enables site-specific covalent coupling driven by drug binding. This innovative approach allows for the creation of first-in-class covalent biologics, which are designed to offer enhanced efficacy and improved safety profiles compared to existing treatments.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, that focuses on drug discovery through its innovative platform targeting solute carrier (SLC) transporters. Established in 2016, the company aims to improve patient outcomes by developing small molecule therapies for various diseases, including those related to immunometabolism, lysosomal function, and mucosal defense. By utilizing advanced chemoproteomics techniques, Jnana accelerates the identification of therapeutic targets, addressing significant unmet medical needs in areas such as immuno-oncology, inflammatory disorders, and neurological diseases. The company's approach seeks to enhance drug discovery efficiency by comprehensively targeting the vast family of membrane proteins associated with SLC transporters.

Primer is an internet company that specializes in utilizing artificial intelligence to analyze extensive text data. By employing machine learning and natural language processing, Primer's platform automates the examination of large datasets, allowing businesses to efficiently parse and collate documents in multiple languages. This technology enables users to uncover insights and generate reports that are comparable to those produced by human analysts. Through its innovative approach, Primer aims to help organizations bridge the intelligence gap and enhance their understanding of complex information, thus facilitating informed decision-making and fostering the ability to respond to emerging trends.

Fortis Therapeutics is a biotechnology company specializing in immuno-oncology, dedicated to developing innovative antibody-drug conjugate therapies targeting CD46. The company focuses on treating late-stage multiple myeloma and prostate cancer, among other indications. Its platform is designed to advance therapies for both adenocarcinoma and neuroendocrine cancers, providing healthcare professionals with effective treatment options for patients facing these advanced stages of cancer.

Janux Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies aimed at generating immune responses to combat tumors while preserving healthy tissue. Utilizing its proprietary tumor-activated T Cell Engager platform technology, Janux targets all three stages of the anti-tumor immune response. The company's approach is designed to enhance the efficacy of cancer treatments by specifically engaging the immune system to identify and eliminate cancer cells.

Pando is the one-stop Basecamp for high-potential dreamers and the ambitious builders who refuse to settle. We leverage world class peer groups and financial tools to supercharge your founder journey. We deliver an experience that aligns incentives to unleash founders’ potential, facilitate connection and realize prosperity.

Figg is a card-linked marketing company that provides a digital advertising platform designed to enhance value through everyday transactions. Its unique platform enables brands to market effectively within a private marketplace that includes banks and publishers. By partnering with these financial institutions and publishers, Figg offers advertiser-funded promotions to consumers, fostering loyalty and engagement. The platform allows consumers to enroll any credit or debit card, facilitating incremental cash-back rewards through targeted offers. With access to powerful transaction data, Figg enables advertisers to reach specific consumer segments with precise targeting and accurate tracking of marketing expenditures, benefiting both businesses and consumers alike.

AristaMD is a healthcare company that features a software platform that helps hospitals and practitioners on improving patient outcomes. It also offers a solution that enables primary care providers to ask questions about patients that they would otherwise refer out and transmit patient clinical notes, history, lab results and images to collaborate on care plans with a panel of on-call, board-certified specialists, all within a matter of hours. The company was founded in 2013 and headquartered in La Jolla, California.

Orion Labs, Inc. offers a voice communication and workflow platform designed for mobile and frontline teams, facilitating secure voice, location, and data messaging across a variety of connected devices and applications. Its product suite includes a Push to Talk app, web-based command center, advanced location services, language translation, and various AI-powered workflows. The platform is compatible with traditional VoIP and Land Mobile Radio systems, and it provides APIs and SDKs for developers to extend its functionalities. Orion Labs serves multiple industries, including hospitality, field services, transportation, and healthcare, selling its solutions primarily online in the United States and Canada. Founded in 2013 and headquartered in San Francisco, the company, originally named OnBeep, was rebranded in 2015 and has since formed strategic alliances with organizations such as ResponderXLabs and the FirstNet Association.

Simulmedia Inc. is a technology company that specializes in digital advertisement targeting for linear television. Founded in 2008 and headquartered in New York, with an additional office in San Francisco, the company offers the VAMOS platform, a data-driven predictive analytics tool for television. Simulmedia's TV+ platform enables advertisers and agencies to effectively reach audiences across both linear television and connected TV, ensuring broad reach and minimizing waste. The company serves marketers, agencies, TV media owners, and distributors, providing them with capabilities for real-time campaign measurement and optimization. By combining the precision of digital advertising with the extensive reach of television, Simulmedia has transformed the landscape of TV advertising.

Seva is a cloud-based information discovery and collaboration platform designed to enhance workplace efficiency for teams. Founded in late 2017 and launched in mid-2018, the company is based in New York City. Seva integrates with various applications, including email, messaging, document management, and code management, to provide knowledge workers with a single source of truth. This platform aims to eliminate the time wasted searching for information by acting as a "digital teammate" that quickly retrieves precise answers, enabling users to access the most pertinent information needed to perform their jobs effectively.

Joy is a wedding company that gives couples a smarter way to plan their big day. Using Joy, couples can create a beautifully-designed wedding website and mobile app, build their All-in-One Registry, manage guest lists and RSVPs, send online or printed Save the Dates, invitations, and eCards, provide travel and accommodations options for guests, host virtual wedding events, create a shared virtual wedding album and virtual guest book, and more. Wedding guests can purchase registry gifts, book travel plans and accommodations, get directions to wedding events via a Google Maps integration, order a ride to wedding events via ride-sharing integrations, add wedding events to their calendars with a click, and more. Based in San Francisco, Joy launched in 2016 through Y Combinator.

Memrise is a language learning platform accessible on iOS, Android, and the web, offering over 150 courses in 25 languages. With more than 40 million registered users, the platform provides a free learning experience without advertisements. Memrise employs innovative teaching methods, utilizing images, science, and flashcards to enhance vocabulary acquisition and language comprehension. While the basic courses are free, users can unlock additional features and learning modes through a Memrise Pro subscription. Since late 2016, Memrise has maintained profitability, reflecting its successful approach to language education.

BotChain enables universal registration, identity validation, audit, and coordination of A.I. agents and autonomous software. The BotChain was created by the team at Talla. After more than two years of building intelligent, AI-driven bots for the enterprise, Talla began pursuing their idea for BotChain. The leadership team represents decades of experience in software development, Artificial Intelligence, startups, and innovation.

Synthorx, Inc. is a biopharmaceutical company based in La Jolla, California, focused on developing innovative cytokine Synthorin programs for the treatment of cancer and autoimmune disorders. The company's lead product candidate, THOR-707, is a variant of recombinant human IL-2 being explored for various solid tumors, both as a standalone treatment and in combination with immune checkpoint inhibitors. Additionally, Synthorx is working on IL-2 Synthorin for autoimmune conditions, IL-10 Synthorin for immuno-oncology, and IL-15 Synthorins to enhance immune regulation. The company employs advanced synthetic biology techniques, utilizing a novel DNA base pair to create proteins with enhanced specificity, safety, and efficacy. These developments enable the manufacturing of improved therapeutics that can better modulate pharmacological properties compared to traditional biologics. Synthorx, which was established in 2014 and previously known as Alinos, Inc., operates as a subsidiary of Sanofi and holds exclusive rights to its innovative synthetic biology technology derived from research at The Scripps Research Institute.

Averon is on a mission to restore sanity in online identity. Our conversion-increasing innovations instantly authenticate mobile users, creating a world where we can all move safely and efficiently around the internet with zero effort and maximum trust—no more frustrating and unsecure login IDs and passwords. Averon's technology is the new gold standard for digital identity—the easiest, fastest and most secure verification solution for users on both WiFi and LTE. Simple to implement and effortless for users, Averon's solutions don't rely on personally identifiable information, providing the most private authentication method in the digital realm. Protected by 35 patents, Averon's methods are trusted by the world's leading ride share and transportation services, digital currencies, cryptocurrency wallets, and global telecommunications companies to deliver the most elegant user experience with the highest caliber security. Join us in helping the online world Be Authentic. For more information, visit www.averon.com

Pando is the one-stop Basecamp for high-potential dreamers and the ambitious builders who refuse to settle. We leverage world class peer groups and financial tools to supercharge your founder journey. We deliver an experience that aligns incentives to unleash founders’ potential, facilitate connection and realize prosperity.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, that focuses on drug discovery through its innovative platform targeting solute carrier (SLC) transporters. Established in 2016, the company aims to improve patient outcomes by developing small molecule therapies for various diseases, including those related to immunometabolism, lysosomal function, and mucosal defense. By utilizing advanced chemoproteomics techniques, Jnana accelerates the identification of therapeutic targets, addressing significant unmet medical needs in areas such as immuno-oncology, inflammatory disorders, and neurological diseases. The company's approach seeks to enhance drug discovery efficiency by comprehensively targeting the vast family of membrane proteins associated with SLC transporters.

ScoreStream, Inc. is a company that develops mobile applications focused on enhancing communication around sporting events, particularly high school sports. Founded in 2012 and based in San Diego, California, the platform allows fans to share crowd-sourced scores, photos, videos, and engage in conversations about games. Its applications are available on both iOS and Android, as well as through a website, facilitating the sharing of local sports content with family, friends, and media outlets. ScoreStream aims to provide accurate and timely reporting for high school sports, tapping into community engagement to enrich the fan experience.

Averon is on a mission to restore sanity in online identity. Our conversion-increasing innovations instantly authenticate mobile users, creating a world where we can all move safely and efficiently around the internet with zero effort and maximum trust—no more frustrating and unsecure login IDs and passwords. Averon's technology is the new gold standard for digital identity—the easiest, fastest and most secure verification solution for users on both WiFi and LTE. Simple to implement and effortless for users, Averon's solutions don't rely on personally identifiable information, providing the most private authentication method in the digital realm. Protected by 35 patents, Averon's methods are trusted by the world's leading ride share and transportation services, digital currencies, cryptocurrency wallets, and global telecommunications companies to deliver the most elegant user experience with the highest caliber security. Join us in helping the online world Be Authentic. For more information, visit www.averon.com

Talla, Inc., founded in 2015 and based in Brookline, Massachusetts, specializes in developing an AI and automation platform aimed at enhancing customer support services. The company offers a comprehensive IT Service Management (ITSM) solution that automates support workflows, allowing users to efficiently access accurate answers to inquiries while simultaneously boosting customer satisfaction and support team productivity. Talla's platform is designed to manage and prioritize requests, automate responses to frequently asked questions, and provide proactive employee education, all within chat applications. Unlike its competitors, Talla's technology improves over time through machine learning and seamlessly integrates with various tools essential for support teams.

Nanonets is an AI-driven company specializing in automating document processing and data extraction workflows. By utilizing advanced Optical Character Recognition (OCR) and deep learning models, Nanonets assists businesses in managing document-intensive processes such as accounts payable, order processing, and insurance underwriting. The platform effectively processes unstructured documents—such as invoices, receipts, and contracts—transforming them into structured data. Nanonets integrates seamlessly with existing systems through APIs, significantly reducing manual effort by up to 90% while delivering high accuracy and efficiency. The solution not only enhances productivity but also offers substantial cost savings, making it a valuable tool for organizations looking to streamline their operations without the need for complex database management.

Smyte Inc. is a Software-as-a-Service company that offers trust and safety solutions for websites and mobile applications. Founded in 2014 and based in San Francisco, Smyte employs a combination of manual heuristics, machine learning, and proprietary reputation data to assist businesses in proactively combating spam, fraud, bots, phishing, harassment, and account takeovers. The company's technology is designed to scale to complex trust and safety challenges, processing nearly five billion online actions each month. Smyte integrates its code into client platforms, allowing it to monitor user interactions and identify potentially harmful activities through an automated labeling system. This system flags suspicious behavior for manual review, enabling enterprises, marketplaces, and social networks to enhance security and maintain user trust. Smyte operates as a subsidiary of Twitter.

Piper Networks specializes in developing advanced tracking solutions for transportation and workforce management, focusing on real-time location awareness in complex environments. Utilizing technologies such as Ultra-Wideband (UWB) and Bluetooth Low Energy (BLE), Piper's proprietary proximity solutions deliver superior accuracy, achieving location precision within 10 centimeters while minimizing signal latency and interference. Their platform not only facilitates reliable wireless communication in challenging settings, such as underground subway tunnels, but also supports a variety of applications including messaging, data capture, and contextual information delivery to users. With a robust content dashboard, clients can create engaging communication options that enhance customer engagement and provide valuable analytics for inventory tracking.

Fortis Therapeutics is a biotechnology company specializing in immuno-oncology, dedicated to developing innovative antibody-drug conjugate therapies targeting CD46. The company focuses on treating late-stage multiple myeloma and prostate cancer, among other indications. Its platform is designed to advance therapies for both adenocarcinoma and neuroendocrine cancers, providing healthcare professionals with effective treatment options for patients facing these advanced stages of cancer.

Avelas Biosciences is focused on enhancing cancer surgery through innovative intraoperative imaging technology. The company's proprietary platform employs activatable cell-penetrating peptides to facilitate real-time diagnosis of metastatic nodes during surgical procedures. This advancement allows oncologic surgeons to create a luminous map of the surgical site, which helps in identifying critical areas and improving surgical precision. By providing this real-time information, Avelas aims to reduce the likelihood of repeat surgeries and ultimately improve patient outcomes, setting a new standard of care in the field of oncology.

Synthorx, Inc. is a biopharmaceutical company based in La Jolla, California, focused on developing innovative cytokine Synthorin programs for the treatment of cancer and autoimmune disorders. The company's lead product candidate, THOR-707, is a variant of recombinant human IL-2 being explored for various solid tumors, both as a standalone treatment and in combination with immune checkpoint inhibitors. Additionally, Synthorx is working on IL-2 Synthorin for autoimmune conditions, IL-10 Synthorin for immuno-oncology, and IL-15 Synthorins to enhance immune regulation. The company employs advanced synthetic biology techniques, utilizing a novel DNA base pair to create proteins with enhanced specificity, safety, and efficacy. These developments enable the manufacturing of improved therapeutics that can better modulate pharmacological properties compared to traditional biologics. Synthorx, which was established in 2014 and previously known as Alinos, Inc., operates as a subsidiary of Sanofi and holds exclusive rights to its innovative synthetic biology technology derived from research at The Scripps Research Institute.

Node, recently acquired by SugarCRM, fuels Sugar's time-aware CX platform to help businesses by automatically forecasting expected outcomes and highlighting previously unforeseen challenges and opportunities. Extending Sugar’s time-aware CX platform, Node’s AI technology adds the most coveted element of time—the future. The combined solution offers wide-ranging capabilities for sales, marketing, and service teams. Node enables users of business applications to see into the future. Powered by Artificial Intuition™ technology, Node is the first turnkey AI-as-a-service platform focused on powering predictable business outcomes, which enterprises can use to quickly and seamlessly build advanced AI into both customer-facing and internal applications without investing years and millions of dollars on risky AI experiments. Applications powered by Node can deliver predictions that enable users to make smarter connections and decisions about how to engage with customers, employees, investors, and partners. Node was founded by Google's youngest employee, Falon Fatemi, and it's renowned technology team includes the Godfather of Search, Louis Monier who created Alta Vista, and Michael Radovancevich former CTO of Taleo and OpenX. Node is backed by Mark Cuban, NEA, Avalon Ventures, and JetBlue Technology Ventures.

Orion Labs, Inc. offers a voice communication and workflow platform designed for mobile and frontline teams, facilitating secure voice, location, and data messaging across a variety of connected devices and applications. Its product suite includes a Push to Talk app, web-based command center, advanced location services, language translation, and various AI-powered workflows. The platform is compatible with traditional VoIP and Land Mobile Radio systems, and it provides APIs and SDKs for developers to extend its functionalities. Orion Labs serves multiple industries, including hospitality, field services, transportation, and healthcare, selling its solutions primarily online in the United States and Canada. Founded in 2013 and headquartered in San Francisco, the company, originally named OnBeep, was rebranded in 2015 and has since formed strategic alliances with organizations such as ResponderXLabs and the FirstNet Association.

Enlibrium is developing novel drugs based on metformin to treat a range of different cancers by reducing cancer energy consumption and reestablishing energy balance. Given their high growth rate and energy requirements, cancers are particularly sensitive to agents that reduce their energy production. Enlibrium was founded based on technology exclusively licensed from UCLA and developed in laboratories headed by Michael Jung, Ph.D. and Richard Pietras, M.D., Ph.D. Enlibrium's investors are Avalon Ventures, TPG Biotech, Correlation Ventures and Osage University Partners.

Skycatch builds technology to autonomously capture, process, and analyze 3D drone data to provide companies with an accurate visualization of the physical world. It is the leading industrial data collection and analytics company, focused on indexing and extracting critical information from the physical world. They use a combination of hardware, software, and artificial intelligence to deliver high precision data at unprecedented speed and ease of use. It was incorporated in 2013 and is based in San Francisco, California.

MOGL is a restaurant rewards app on a mission to end hunger in the US. Members earn 10% cash-back at 1000's of participating restaurants by paying with a linked credit or debit card. Within seconds of paying they will get an alert on their phone giving them the option to donate some or all of the cash-back to a local food bank. Members can track the progress being made in their city using the Hunger Tracker and compete against friends to see who can donate the most meals. MOGL Loyalty Services, Inc. was founded in 2010 and is based in Solana Beach, California.

AeroFS offers an enterprise file synchronization and collaboration platform aimed at enhancing the way creative agencies, consultants, freelancers, and teams work together. Its flagship product, Amium, facilitates more intuitive and efficient sharing of information and ideas, significantly improving collaboration across organizational boundaries. The platform operates on a private cloud-like infrastructure, allowing clients to store data on designated devices while maintaining the ability to run entirely behind firewalls, including authentication measures. AeroFS prioritizes user privacy, control, and scalability, ensuring that both administrators and end-users benefit from a secure and streamlined collaboration experience. The company continuously updates its software, providing users with the latest features and improvements to enhance their collaborative efforts.

Ankasa Regenerative Therapeutics is a biopharmaceutical company focused on advancing tissue healing by harnessing the capabilities of stem cell reactivation. Established in 2014 and based in La Jolla, California, the company is developing proprietary formulations of a WNT stem cell activator aimed at accelerating tissue repair across various degenerative conditions, including those affecting bone, cartilage, skin, muscle, vasculature, and the central nervous system. Its innovative approach has shown promise in enhancing the osteogenic properties of patient-derived stem cells, particularly in reconstructive surgeries, thereby improving bone formation and reducing the need for revision surgeries and their associated complications. The company's preclinical models indicate that its therapies may offer superior outcomes for bone reformation compared to existing standards of care.

Indix offers a comprehensive Products Platform that provides businesses with essential product information and commerce-ready services at a competitive cost. By leveraging artificial intelligence and a vast collection of product data—including pricing, availability, and seller information—Indix enables organizations to enhance their digital product catalogs. The platform also supports businesses in making informed decisions, improving their product portfolio management, and increasing sales efficiency. Through its focus on big data, analytics, and visualization, Indix empowers clients to develop innovative strategies for buying and selling products effectively.

Vook, now known as Pronoun, is a publishing firm that focuses on both digital and print formats. The company specializes in ebook creation, distribution, cover design, and copy editing services. By leveraging technology and data, Vook aims to empower authors, enabling them to publish their works more efficiently while maintaining both creative and financial control. The firm seeks to enhance the publishing process, allowing authors to market their books effectively and connect with their audiences.

Calporta is developing selective small molecule agonists of TRPML1 (transient receptor potential cation channel, mucolipin subfamily, member 1) for the treatment of Niemann-Pick C Disease (NPC) and other lysosomal storage diseases. Mutations that cause NPC lead to impaired intracellular lipid trafficking and lead to lysosomal accumulation of cholesterol and biolipds. TRPML1 is an ion channel in the lysosome and a key regulator of lysosomal trafficking processes. Impaired TRPML1 function has been implicated in multiple pathological conditions, including NPC. Agonists of TRPML1 restore calcium efflux and normalize lysosomal trafficking and function. In addition to NPC and other lysosomal storage diseases, agonists of TRPML1 may have broad potential in other diseases such as muscular dystrophy and various taopathies such as Alzheimer's disease. Calporta's approach is based on research from the lab of Haoxing Xu, Ph.D., at the University of Michigan.

Cadherx Therapeutics develops therapeutic antibodies targeting soluble E-cadherin.

BookBub is a rapidly growing startup launched by serial entrepreneurs and run by a team gathered from the publishing and tech industries. Every day millions of readers use our service to discover great books, and thousands of leading publishers and authors work with us to drive sales and find new fans. Connecting readers with great deals on ebooks is just the beginning for BookBub. The rise of digital publishing is altering the way books are found, purchased, and read. We’re expanding our team to help address the challenges and opportunities of the publishing industry while continuing to help readers find books and authors they’ll love.

Tapad, Inc. is a marketing technology company that specializes in identity-based marketing solutions. It offers a suite of products, including the Tapad Customer Data Platform and the Tapad Graph, which allows users to integrate first-party data with predictive modeling to enhance marketing outcomes. The Tapad Graph assimilates vast amounts of data to reveal the connections between various devices, such as smartphones, tablets, and connected TVs, enabling a comprehensive understanding of consumer behavior. Additionally, Tapad provides Device Graph Access for targeted marketing and measurement, an Applied Analytics suite to evaluate campaign performance, and Dynamic Audiences for precise consumer targeting across devices. The company serves a diverse clientele, including agency trading desks, publishers, marketing technology firms, and Fortune 500 brands. Founded in 2010 and headquartered in New York, Tapad operates globally with offices in several major cities, including London, Chicago, Oslo, Singapore, and Tokyo. As of late 2020, Tapad functions as a subsidiary of Experian plc.

Cardeas Pharma is focused on developing a novel antibiotic formulation that combines two drugs to effectively target highly resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Acinetobacter baumannii, as well as carbapenem-resistant Enterobacteriaceae. This formulation is also effective against biofilms and Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). The antibiotics are delivered through a single-patient use nebulizer that produces small, uniform aerosol droplets, allowing for targeted delivery to the small airways and alveoli. By integrating this innovative antibiotic formulation with advanced drug-delivery technology, Cardeas Pharma aims to improve clinical outcomes for patients suffering from serious, hospital-acquired respiratory infections.

ScoreStream, Inc. is a company that develops mobile applications focused on enhancing communication around sporting events, particularly high school sports. Founded in 2012 and based in San Diego, California, the platform allows fans to share crowd-sourced scores, photos, videos, and engage in conversations about games. Its applications are available on both iOS and Android, as well as through a website, facilitating the sharing of local sports content with family, friends, and media outlets. ScoreStream aims to provide accurate and timely reporting for high school sports, tapping into community engagement to enrich the fan experience.

Nanigans is a provider of advertising automation software designed to enhance the capabilities of in-house performance marketing teams. The company offers its services as a Software-as-a-Service platform, featuring programmatic media buying, predictive revenue optimization, and real-time business intelligence. These tools allow clients to optimize their revenue generation across various digital channels. Headquartered in Boston, Nanigans also operates offices in major cities including New York, San Francisco, Seattle, London, Sydney, and Singapore.

Primer is an internet company that specializes in utilizing artificial intelligence to analyze extensive text data. By employing machine learning and natural language processing, Primer's platform automates the examination of large datasets, allowing businesses to efficiently parse and collate documents in multiple languages. This technology enables users to uncover insights and generate reports that are comparable to those produced by human analysts. Through its innovative approach, Primer aims to help organizations bridge the intelligence gap and enhance their understanding of complex information, thus facilitating informed decision-making and fostering the ability to respond to emerging trends.

Primer is an internet company that specializes in utilizing artificial intelligence to analyze extensive text data. By employing machine learning and natural language processing, Primer's platform automates the examination of large datasets, allowing businesses to efficiently parse and collate documents in multiple languages. This technology enables users to uncover insights and generate reports that are comparable to those produced by human analysts. Through its innovative approach, Primer aims to help organizations bridge the intelligence gap and enhance their understanding of complex information, thus facilitating informed decision-making and fostering the ability to respond to emerging trends.

StackRox, Inc. develops a Kubernetes-native container security platform that helps enterprises secure their cloud-native applications throughout the entire life cycle, from build to deploy to runtime. The platform offers deep visibility into container and microservice activity, enabling users to discover and categorize assets effectively. It protects cloud workloads by detecting various cyber threats, including code injection and privilege escalation, while orchestrating threat responses through policy-driven workflows. StackRox integrates seamlessly with existing DevOps and security tools, allowing teams to operationalize security measures efficiently. The company serves a diverse clientele, including cloud-native organizations, Global 2000 enterprises, and government agencies. Founded in 2014, StackRox is headquartered in Mountain View, California.

Redbooth is a task and project management platform that provides a single place for team collaboration such as tasks, discussions, and file sharing. Redbooth is simple and flexible to use, enabling project teams and departments at thousands of companies to get work done. Redbooth is used by over 400,000 organizations, including AT&T, Avis, BBC, Canal+, Cisco, Deutsche Telekom, Duke University, Harvard University, Intuit, Novartis, Subaru, ReMax, and Volkswagen Audi. Founded in 2008, the company is privately held and headquartered in Palo Alto, California.

MOGL is a restaurant rewards app on a mission to end hunger in the US. Members earn 10% cash-back at 1000's of participating restaurants by paying with a linked credit or debit card. Within seconds of paying they will get an alert on their phone giving them the option to donate some or all of the cash-back to a local food bank. Members can track the progress being made in their city using the Hunger Tracker and compete against friends to see who can donate the most meals. MOGL Loyalty Services, Inc. was founded in 2010 and is based in Solana Beach, California.

Empyr, Inc. is an online-to-offline advertisement platform based in San Diego, California, that connects publishers and advertisers by tracking online advertisements to offline purchases in real-time. Founded in 2011, the company specializes in card-linked offers, allowing consumers to earn cashback at offline merchants simply by using their debit or credit cards. This seamless integration taps into a significant market opportunity, as a substantial amount of offline commerce driven by online and mobile channels remains untracked and unmonetized. Empyr collaborates with major corporations, including tech companies, banks, airlines, and hotels, to facilitate these commerce programs. Its partnerships extend to over 1,500 affiliates, including notable names like Microsoft and LivingSocial. By enabling merchants to link online marketing efforts directly to actual offline sales, Empyr provides a valuable service in the evolving landscape of digital commerce. The company has raised $35 million through its parent company, Mogl, and employs around 60 staff members.

StackIQ, Inc. is a technology company that specializes in server automation and infrastructure management. Founded in 2006 and based in Solana Beach, California, the company offers a software suite that automates the deployment and management of bare metal environments for various applications, including big data and private cloud automation. Its flagship product, Stacki, is an open-source Linux server provisioning tool that transforms bare hardware into fully operational clusters by handling tasks such as operating system installation, network configuration, and RAID setup. Additionally, StackIQ has developed Stacki Ace, which extends these capabilities to Raspberry Pi devices, and Stacki Pro, which supports the installation of SUSE Linux Enterprise Server and multiple distributions from a single interface. In 2011, the company changed its name from Clustercorp, Inc. and, as of 2017, operates as a subsidiary of Teradata Corporation.

Kinvey, Inc. offers a mobile backend as a service (mBaaS) platform designed to simplify the development of cloud backends for mobile, tablet, and web applications. Established in 2008 and based in Boston, Massachusetts, Kinvey enables developers to focus exclusively on application development without the burden of managing server infrastructure or integrating various cloud services. The platform provides automated API generation, allowing developers to seamlessly connect their applications to backend services. Kinvey's solutions cater to a diverse range of industries, including healthcare, finance, utilities, and media, facilitating features such as data storage, user management, push notifications, and analytics. As of June 2017, Kinvey operates as a subsidiary of Progress Software Corporation.

Thyritope Biosciences is developing therapeutics that target thyroid stimulating auto-antibodies, which are the causative drivers of Graves' hyperthyroidism and Graves' orbitopathy. Graves' disease is an autoimmune disorder caused by antibodies that over-stimulate the thyroid, causing excessive thyroid hormone production. The same antibodies stimulate the tissue around the eyes, resulting in an increase of orbital fat and extra-ocular muscle volume which causes the bulging of the eyes characteristic of Graves' orbitopathy.

Silarus Therapeutics is developing therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. Erythroferrone is a recently-discovered hormone that regulates the iron supply for red blood cell production. Iron deficiency, also known as anemia, is a condition in which blood does not contain the normal amount of red blood cells or lacks the proper amount of hemoglobin. This, in turn, lowers the amount of oxygen-rich blood in circulation, causing shortness of breath, dizziness or headaches.

Sidecar Technologies operates a B2B delivery transportation network that connects retailers with customers through a fleet of everyday drivers using their personal vehicles. Founded in San Francisco in 2011, Sidecar focuses on creating a convenient and affordable transportation solution powered by pre-vetted drivers who can choose when to offer rides. The company emphasizes safety through a comprehensive system that includes background checks, rating systems for both drivers and riders, GPS tracking, and real-time trip sharing. Currently, Sidecar operates in ten major U.S. cities and has facilitated over half a million rides, demonstrating its commitment to enhancing the delivery and driving experience.

Avelas Biosciences is focused on enhancing cancer surgery through innovative intraoperative imaging technology. The company's proprietary platform employs activatable cell-penetrating peptides to facilitate real-time diagnosis of metastatic nodes during surgical procedures. This advancement allows oncologic surgeons to create a luminous map of the surgical site, which helps in identifying critical areas and improving surgical precision. By providing this real-time information, Avelas aims to reduce the likelihood of repeat surgeries and ultimately improve patient outcomes, setting a new standard of care in the field of oncology.

ScoreStream, Inc. is a company that develops mobile applications focused on enhancing communication around sporting events, particularly high school sports. Founded in 2012 and based in San Diego, California, the platform allows fans to share crowd-sourced scores, photos, videos, and engage in conversations about games. Its applications are available on both iOS and Android, as well as through a website, facilitating the sharing of local sports content with family, friends, and media outlets. ScoreStream aims to provide accurate and timely reporting for high school sports, tapping into community engagement to enrich the fan experience.

Tapad, Inc. is a marketing technology company that specializes in identity-based marketing solutions. It offers a suite of products, including the Tapad Customer Data Platform and the Tapad Graph, which allows users to integrate first-party data with predictive modeling to enhance marketing outcomes. The Tapad Graph assimilates vast amounts of data to reveal the connections between various devices, such as smartphones, tablets, and connected TVs, enabling a comprehensive understanding of consumer behavior. Additionally, Tapad provides Device Graph Access for targeted marketing and measurement, an Applied Analytics suite to evaluate campaign performance, and Dynamic Audiences for precise consumer targeting across devices. The company serves a diverse clientele, including agency trading desks, publishers, marketing technology firms, and Fortune 500 brands. Founded in 2010 and headquartered in New York, Tapad operates globally with offices in several major cities, including London, Chicago, Oslo, Singapore, and Tokyo. As of late 2020, Tapad functions as a subsidiary of Experian plc.

Skycatch builds technology to autonomously capture, process, and analyze 3D drone data to provide companies with an accurate visualization of the physical world. It is the leading industrial data collection and analytics company, focused on indexing and extracting critical information from the physical world. They use a combination of hardware, software, and artificial intelligence to deliver high precision data at unprecedented speed and ease of use. It was incorporated in 2013 and is based in San Francisco, California.

BookBub is a rapidly growing startup launched by serial entrepreneurs and run by a team gathered from the publishing and tech industries. Every day millions of readers use our service to discover great books, and thousands of leading publishers and authors work with us to drive sales and find new fans. Connecting readers with great deals on ebooks is just the beginning for BookBub. The rise of digital publishing is altering the way books are found, purchased, and read. We’re expanding our team to help address the challenges and opportunities of the publishing industry while continuing to help readers find books and authors they’ll love.

Otonomy, Inc. is a biopharmaceutical company based in San Diego, California, that specializes in developing therapeutics for ear disorders. The company markets OTIPRIO, a ciprofloxacin otic suspension used during tympanostomy tube placement surgery in pediatric patients. Otonomy is advancing several product candidates, including OTIVIDEX, a sustained-exposure formulation of dexamethasone for Ménière’s disease; OTO-313, a formulation for tinnitus in Phase I/II trials; and OTO-413, aimed at repairing cochlear synaptopathy and addressing speech-in-noise hearing difficulties. Additionally, the company is developing OTO-510, designed to prevent cisplatin-induced hearing loss, and OTO-6XX, which focuses on hair cell regeneration for severe hearing loss. Otonomy employs a proprietary formulation platform that enables sustained drug delivery from a single administration, enhancing treatment options for various ear-related conditions. The company also has strategic collaborations for gene therapy aimed at congenital hearing loss. Founded in 2008, Otonomy continues to lead advancements in otology through innovation and research.

Synthorx, Inc. is a biopharmaceutical company based in La Jolla, California, focused on developing innovative cytokine Synthorin programs for the treatment of cancer and autoimmune disorders. The company's lead product candidate, THOR-707, is a variant of recombinant human IL-2 being explored for various solid tumors, both as a standalone treatment and in combination with immune checkpoint inhibitors. Additionally, Synthorx is working on IL-2 Synthorin for autoimmune conditions, IL-10 Synthorin for immuno-oncology, and IL-15 Synthorins to enhance immune regulation. The company employs advanced synthetic biology techniques, utilizing a novel DNA base pair to create proteins with enhanced specificity, safety, and efficacy. These developments enable the manufacturing of improved therapeutics that can better modulate pharmacological properties compared to traditional biologics. Synthorx, which was established in 2014 and previously known as Alinos, Inc., operates as a subsidiary of Sanofi and holds exclusive rights to its innovative synthetic biology technology derived from research at The Scripps Research Institute.

Indix offers a comprehensive Products Platform that provides businesses with essential product information and commerce-ready services at a competitive cost. By leveraging artificial intelligence and a vast collection of product data—including pricing, availability, and seller information—Indix enables organizations to enhance their digital product catalogs. The platform also supports businesses in making informed decisions, improving their product portfolio management, and increasing sales efficiency. Through its focus on big data, analytics, and visualization, Indix empowers clients to develop innovative strategies for buying and selling products effectively.

Sidecar Technologies operates a B2B delivery transportation network that connects retailers with customers through a fleet of everyday drivers using their personal vehicles. Founded in San Francisco in 2011, Sidecar focuses on creating a convenient and affordable transportation solution powered by pre-vetted drivers who can choose when to offer rides. The company emphasizes safety through a comprehensive system that includes background checks, rating systems for both drivers and riders, GPS tracking, and real-time trip sharing. Currently, Sidecar operates in ten major U.S. cities and has facilitated over half a million rides, demonstrating its commitment to enhancing the delivery and driving experience.

MOGL is a restaurant rewards app on a mission to end hunger in the US. Members earn 10% cash-back at 1000's of participating restaurants by paying with a linked credit or debit card. Within seconds of paying they will get an alert on their phone giving them the option to donate some or all of the cash-back to a local food bank. Members can track the progress being made in their city using the Hunger Tracker and compete against friends to see who can donate the most meals. MOGL Loyalty Services, Inc. was founded in 2010 and is based in Solana Beach, California.

Empyr, Inc. is an online-to-offline advertisement platform based in San Diego, California, that connects publishers and advertisers by tracking online advertisements to offline purchases in real-time. Founded in 2011, the company specializes in card-linked offers, allowing consumers to earn cashback at offline merchants simply by using their debit or credit cards. This seamless integration taps into a significant market opportunity, as a substantial amount of offline commerce driven by online and mobile channels remains untracked and unmonetized. Empyr collaborates with major corporations, including tech companies, banks, airlines, and hotels, to facilitate these commerce programs. Its partnerships extend to over 1,500 affiliates, including notable names like Microsoft and LivingSocial. By enabling merchants to link online marketing efforts directly to actual offline sales, Empyr provides a valuable service in the evolving landscape of digital commerce. The company has raised $35 million through its parent company, Mogl, and employs around 60 staff members.

Quippi offers a new fee-free alternative to international money transfer services. Quippi international gift cards are available for purchase in the United States and are redeemable by loved ones in leading retailers in Mexico. Quippi cards carry no fees, no commissions, and no other hidden charges for the purchaser or recipient. Quippi is simple: the customer purchases a gift card online or in-store in the US and communicates the Quippi PIN code to the recipient in Mexico via text, email or telephone. The recipient in Mexico can then shop immediately at one of Quippi’s many retail partners. Quippi has 7 partners in Mexico offering products ranging from groceries, clothing, appliances, home goods, educational supplies, health goods and services, and mobile recharge. While Quippi will continue to expand its retail partner network in Mexico, the company plans to expand throughout Latin America and the world!

Chartio is a cloud-based data exploration platform aimed at democratizing data access and analysis. Founded in June 2010 and based in San Francisco, the company provides an intuitive solution that enables users to connect various data sources and create dynamic dashboards without requiring SQL knowledge. With its drag-and-drop interface and robust data pipeline, Chartio facilitates real-time querying, analysis, and tracking of key metrics, allowing businesses to easily identify trends, patterns, and anomalies in their data. By bypassing the need for data warehousing, Chartio helps organizations optimize decision-making and leverage complex data to drive growth while addressing security concerns.

Avelas Biosciences is focused on enhancing cancer surgery through innovative intraoperative imaging technology. The company's proprietary platform employs activatable cell-penetrating peptides to facilitate real-time diagnosis of metastatic nodes during surgical procedures. This advancement allows oncologic surgeons to create a luminous map of the surgical site, which helps in identifying critical areas and improving surgical precision. By providing this real-time information, Avelas aims to reduce the likelihood of repeat surgeries and ultimately improve patient outcomes, setting a new standard of care in the field of oncology.

Simulmedia Inc. is a technology company that specializes in digital advertisement targeting for linear television. Founded in 2008 and headquartered in New York, with an additional office in San Francisco, the company offers the VAMOS platform, a data-driven predictive analytics tool for television. Simulmedia's TV+ platform enables advertisers and agencies to effectively reach audiences across both linear television and connected TV, ensuring broad reach and minimizing waste. The company serves marketers, agencies, TV media owners, and distributors, providing them with capabilities for real-time campaign measurement and optimization. By combining the precision of digital advertising with the extensive reach of television, Simulmedia has transformed the landscape of TV advertising.

Sitari Pharmaceuticals is a operator of a biotechnology company intended to develop treatments for multiple disease indications with an initial focus in celiac disease.

Redbooth is a task and project management platform that provides a single place for team collaboration such as tasks, discussions, and file sharing. Redbooth is simple and flexible to use, enabling project teams and departments at thousands of companies to get work done. Redbooth is used by over 400,000 organizations, including AT&T, Avis, BBC, Canal+, Cisco, Deutsche Telekom, Duke University, Harvard University, Intuit, Novartis, Subaru, ReMax, and Volkswagen Audi. Founded in 2008, the company is privately held and headquartered in Palo Alto, California.

Otonomy, Inc. is a biopharmaceutical company based in San Diego, California, that specializes in developing therapeutics for ear disorders. The company markets OTIPRIO, a ciprofloxacin otic suspension used during tympanostomy tube placement surgery in pediatric patients. Otonomy is advancing several product candidates, including OTIVIDEX, a sustained-exposure formulation of dexamethasone for Ménière’s disease; OTO-313, a formulation for tinnitus in Phase I/II trials; and OTO-413, aimed at repairing cochlear synaptopathy and addressing speech-in-noise hearing difficulties. Additionally, the company is developing OTO-510, designed to prevent cisplatin-induced hearing loss, and OTO-6XX, which focuses on hair cell regeneration for severe hearing loss. Otonomy employs a proprietary formulation platform that enables sustained drug delivery from a single administration, enhancing treatment options for various ear-related conditions. The company also has strategic collaborations for gene therapy aimed at congenital hearing loss. Founded in 2008, Otonomy continues to lead advancements in otology through innovation and research.

Conjur offers a DevOps security software platform that helps organizations secure their cloud environments while automating infrastructure processes. The platform focuses on identity and access management, enabling enterprises to identify, authorize, and audit all service and user identities across various systems, including cloud services, virtual machines, and containers. By addressing operational, compliance, and security challenges, Conjur allows customers to protect sensitive IT systems and monitor access in real-time. The software enforces security policies, reduces vulnerability points, and generates detailed activity reports for compliance and security audits. As organizations increasingly adopt cloud computing, Conjur provides essential tools for security-conscious enterprises to deploy sensitive workloads confidently. Its notable clientele includes companies such as Discovery Communications, AOL, and Cisco. Conjur is backed by seed funding from investment firms like Avalon Partners and Amplify Partners.

Happy Cloud, Inc. is a technology company that specializes in an on-demand cloud-based gaming platform, enabling users to access games without the lengthy download and installation processes typical of traditional gaming. Founded in 2009 and headquartered in New York, with an additional office in Beit Shemesh, Israel, the company utilizes patent-pending technology that pre-installs and pre-packages games on its network. This innovative approach eliminates the need for server-side rendering and video streaming, ensuring a seamless gaming experience without lag, akin to playing from a physical disc. Happy Cloud's platform is designed for scalability and efficiency, allowing gamers to enjoy immediate access to a wide range of titles while bypassing the complexities of source code integration.

Cloudant is a provider of distributed database-as-a-service (DBaaS) that enables developers of web and mobile applications to concentrate on product development rather than database management and scaling. Founded in 2008 in Cambridge, Massachusetts, by three MIT physicists, Cloudant emerged from their need for improved tools to handle large data sets from the Large Hadron Collider. The company built a globally scalable, fault-tolerant data layer using Apache CouchDB, catering to the needs of fast-growing applications. Cloudant now manages and serves operational data for thousands of developers and hundreds of customers worldwide, offering robust data tools for loading, storing, analyzing, and distributing application data.

Nanigans is a provider of advertising automation software designed to enhance the capabilities of in-house performance marketing teams. The company offers its services as a Software-as-a-Service platform, featuring programmatic media buying, predictive revenue optimization, and real-time business intelligence. These tools allow clients to optimize their revenue generation across various digital channels. Headquartered in Boston, Nanigans also operates offices in major cities including New York, San Francisco, Seattle, London, Sydney, and Singapore.

Indix offers a comprehensive Products Platform that provides businesses with essential product information and commerce-ready services at a competitive cost. By leveraging artificial intelligence and a vast collection of product data—including pricing, availability, and seller information—Indix enables organizations to enhance their digital product catalogs. The platform also supports businesses in making informed decisions, improving their product portfolio management, and increasing sales efficiency. Through its focus on big data, analytics, and visualization, Indix empowers clients to develop innovative strategies for buying and selling products effectively.

Tapad, Inc. is a marketing technology company that specializes in identity-based marketing solutions. It offers a suite of products, including the Tapad Customer Data Platform and the Tapad Graph, which allows users to integrate first-party data with predictive modeling to enhance marketing outcomes. The Tapad Graph assimilates vast amounts of data to reveal the connections between various devices, such as smartphones, tablets, and connected TVs, enabling a comprehensive understanding of consumer behavior. Additionally, Tapad provides Device Graph Access for targeted marketing and measurement, an Applied Analytics suite to evaluate campaign performance, and Dynamic Audiences for precise consumer targeting across devices. The company serves a diverse clientele, including agency trading desks, publishers, marketing technology firms, and Fortune 500 brands. Founded in 2010 and headquartered in New York, Tapad operates globally with offices in several major cities, including London, Chicago, Oslo, Singapore, and Tokyo. As of late 2020, Tapad functions as a subsidiary of Experian plc.

Simulmedia Inc. is a technology company that specializes in digital advertisement targeting for linear television. Founded in 2008 and headquartered in New York, with an additional office in San Francisco, the company offers the VAMOS platform, a data-driven predictive analytics tool for television. Simulmedia's TV+ platform enables advertisers and agencies to effectively reach audiences across both linear television and connected TV, ensuring broad reach and minimizing waste. The company serves marketers, agencies, TV media owners, and distributors, providing them with capabilities for real-time campaign measurement and optimization. By combining the precision of digital advertising with the extensive reach of television, Simulmedia has transformed the landscape of TV advertising.

Welcome to LoopIt, where you can get great shopping advice from friends & experts and help others by sharing your opinons & experiences. We are just getting started, but with your help, we can build a great community that is not only helpful, but fun.

Avelas Biosciences is focused on enhancing cancer surgery through innovative intraoperative imaging technology. The company's proprietary platform employs activatable cell-penetrating peptides to facilitate real-time diagnosis of metastatic nodes during surgical procedures. This advancement allows oncologic surgeons to create a luminous map of the surgical site, which helps in identifying critical areas and improving surgical precision. By providing this real-time information, Avelas aims to reduce the likelihood of repeat surgeries and ultimately improve patient outcomes, setting a new standard of care in the field of oncology.

Kaltura Inc. is a video platform provider serving a diverse range of sectors, including enterprises, media companies, service providers, and educational institutions. Founded in 2006 and based in New York, the company offers a comprehensive Video Experience Cloud that includes live, real-time, and on-demand video products. Its solutions encompass a variety of applications such as corporate training, video marketing, and virtual classroom environments, with specialized services tailored for educational and media sectors. Kaltura's platform supports multiple deployment options, including Software-as-a-Service and on-premise solutions, catering to a global clientele that engages hundreds of millions of viewers across various contexts, including communication, collaboration, and entertainment. The company primarily generates revenue from its Enterprise, Education, and Technology segment, with a significant portion coming from the United States.

Pingup provides direct, convenient access to the real-time scheduling availability of local businesses nationwide, anytime, anywhere - putting the power of action into the hands of the mobile consumer. With its mobile API, Pingup enables directories and local listings providers to quickly and seamlessly bring the power of "book it now" to mobile consumers everywhere. With more than 30,000 properties across 200 business categories on the Pingup platform, the company continues to add thousands of new businesses to its network each month. The company is headquartered in Boston’s Innovation District and backed by Avalon Ventures.

Selectable Media Inc. specializes in video advertising solutions tailored for brands and publishers. The company offers a range of services, including Selectable Value Exchange, which allows audiences to access content and services in return for interacting with brand advertisements. It also provides Selectable Sponsored Stories that distribute branded video content in contextually relevant environments. For publishers, Selectable Media's offerings, such as Content-Unlock and Value Exchange, facilitate consumer access to content by engaging with advertising or subscriptions. The company's partnerships span various sectors, including newspapers, magazines, mobile games, and Wi-Fi providers in public spaces. By collaborating with content providers across multiple devices, Selectable Media enables users to unlock digital content and services through brand interaction. Established in 2005 and based in New York, Selectable Media was formerly known as Nabbr.com Corp. and rebranded in 2007. As of December 31, 2014, it operates as a subsidiary of Meredith Corporation.

Shelby.tv is the best way to discover and enjoy web video. Now available in the App Store, the Shelby.tv app delivers you a personalized channel of videos from sources like YouTube, Vimeo, Hulu, Blip, and DailyMotion, as well as video shared by your friends on Twitter, Tumblr, and Facebook. Over time, Shelby.tv gets smart about what you like and don’t like and improves recommendations to give you that perfect daily dose of video entertainment.

Backupify, a Datto brand, specializes in cloud-to-cloud backup software designed to safeguard cloud-based data for businesses. The company offers essential features such as data retention, ransomware protection, and SharePoint backup, which enable both end users and IT administrators to maintain confidence in the safety and accessibility of their critical business information. By addressing risks associated with data loss from user errors, external attacks, and service outages, Backupify provides a comprehensive solution that enhances data protection and control in the cloud.

Kinvey, Inc. offers a mobile backend as a service (mBaaS) platform designed to simplify the development of cloud backends for mobile, tablet, and web applications. Established in 2008 and based in Boston, Massachusetts, Kinvey enables developers to focus exclusively on application development without the burden of managing server infrastructure or integrating various cloud services. The platform provides automated API generation, allowing developers to seamlessly connect their applications to backend services. Kinvey's solutions cater to a diverse range of industries, including healthcare, finance, utilities, and media, facilitating features such as data storage, user management, push notifications, and analytics. As of June 2017, Kinvey operates as a subsidiary of Progress Software Corporation.

Byliner is a digital publishing company based in San Francisco that focuses on delivering concise literary works, referred to as e-shorts, which are designed to be read in two hours or less. The company collaborates directly with writers to provide a platform for their stories, allowing readers to purchase individual pieces through major digital bookstores. Additionally, Byliner offers a subscription service that grants members access to an exclusive community of authors, featuring a collection of premium content, including rare and previously unseen stories. Through its offerings, Byliner aims to enhance readers' personal skill development and effective self-expression by providing insightful articles on various topics, including books and communication.

Cardeas Pharma is focused on developing a novel antibiotic formulation that combines two drugs to effectively target highly resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Acinetobacter baumannii, as well as carbapenem-resistant Enterobacteriaceae. This formulation is also effective against biofilms and Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). The antibiotics are delivered through a single-patient use nebulizer that produces small, uniform aerosol droplets, allowing for targeted delivery to the small airways and alveoli. By integrating this innovative antibiotic formulation with advanced drug-delivery technology, Cardeas Pharma aims to improve clinical outcomes for patients suffering from serious, hospital-acquired respiratory infections.